我要投票 莎普爱思在滴眼液行业中的票数:159
· 外 推 电 报 ·
2025-02-23 04:37:06 星期日

【莎普爱思是哪个国家的品牌?】

莎普爱思是什么牌子?「莎普爱思」是 浙江莎普爱思药业股份有限公司 旗下著名品牌。该品牌发源于浙江,由创始人陈德康在2000-07-17期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力莎普爱思品牌出海!通过在本页面挂载莎普爱思品牌的产品链接和联系邮箱,可以提高莎普爱思产品曝光!跨境电商爆单神器,目前只要100元/年哦~

公司自1978年建厂以来,经历了从“国营浙江平湖制药厂”转制成“浙江平湖制药厂(股份合作)”到“浙江平湖莎普爱思制药有限公司”,再到“浙江莎普爱思制药有限公司”,最终于2008年12月15日更名为“浙江莎普爱思药业股份有限公司”,目前注册资金为4900万元人民币。

公司作为一家专业从事药品研发、生产、经营的综合性制药企业,先后被列为“国家高新技术企业”、“浙江省百家最具投资价值企业”、“浙江省千家成长之星企业”、“浙江省级企业技术中心”、“省级高新技术研究开发中心”、“浙江省标准创新型企业”、“嘉兴市重点企业技术创新团队”、“院士专家工作站”等多项荣誉称号。

目前公司拥有大容量注射剂(玻璃瓶、塑料瓶和多层共挤膜袋)、口服溶液剂、滴眼剂、片剂(含头孢菌素类)、硬胶囊剂(含头孢菌素类)、栓剂、颗粒剂(含头孢菌素类)、干混悬剂(含头孢菌素类)、冲洗剂共10个剂型,近百种规格的产品批准文号。抗白内障新药“莎普爱思”滴眼液和抗青光眼新药“达靓”滴眼液被列入“国家火炬计划项目”。“莎普爱思”滴眼液还荣获国家重点科技攻关项目、国家重点新产品、浙江省名牌产品等多个称号,是国内第一个国家二类眼科专科新药。

几十年来,公司凭着优质的产品,良好的信誉,在市场竞争日益激烈的情况下,赢得了市场,产品销往全国各地,取得了良好的经济效益。近年来公司的产品销量与销售额都呈现出逐年增涨的态势,是平湖市重点扶持的股改上市企业。

在竞争激烈的医药市场中,我公司始终坚持科技兴业、加强管理、保证质量,不断推出各种自主研发的新产品。公司秉承“科技创新、求是进取、优质高效、和谐健康”的企业精神,不断寻求创新与突破,逐步使公司成为现代化、高科技制药企业。

莎普爱思的未来将坚持以市场为导向,发展为主题,科技创新为核心。以保护和增进人民健康、提高人民福祉为目标。我们确信莎普爱思的无限“关爱”会遍及中国,走向世界。

英文翻译:Since its establishment in 1978, the company has gone through the transformation from "state-owned Zhejiang Pinghu pharmaceutical factory" to "Zhejiang Pinghu pharmaceutical factory (joint stock cooperation)" to "Zhejiang Pinghu sapais Pharmaceutical Co., Ltd." and then to "Zhejiang sapais Pharmaceutical Co., Ltd." and finally changed its name to "Zhejiang sapais pharmaceutical Co., Ltd." on December 15, 2008, with the current registered capital of 49 million yuan RMB. As a comprehensive pharmaceutical enterprise specializing in drug R & D, production and operation, the company has been listed as "national high-tech enterprise", "one hundred enterprises with the most investment value in Zhejiang Province", "one thousand growth star enterprises in Zhejiang Province", "Zhejiang provincial enterprise technology center", "provincial high-tech research and development center", "Zhejiang standard innovation enterprise" "Jiaxing key enterprise technology innovation team", "academician expert workstation" and other honorary titles. At present, the company has 10 dosage forms of large capacity injection (glass bottles, plastic bottles and multi-layer coextrusion film bags), oral solution, eye drops, tablets (including cephalosporins), hard capsules (including cephalosporins), suppositories, granules (including cephalosporins), dry suspension (including cephalosporins), washing agents, and approval numbers of nearly 100 specifications of products. The new anti cataract drug "sapais" eye drops and the new anti glaucoma drug "Daliang" eye drops are listed in the "National Torch Program project". "Saps eye drops" also won the titles of national key scientific and technological research projects, national key new products, Zhejiang famous brand products, etc., and is the first national class II ophthalmic specialty new drug in China. In the past few decades, with its high quality products and good reputation, the company has won the market and sold its products to all parts of the country under the increasingly fierce market competition, and achieved good economic benefits. In recent years, the sales volume and sales volume of the company have been increasing year by year. It is a listed company supported by Pinghu City. In the highly competitive pharmaceutical market, our company always adheres to the development of science and technology, strengthening management, ensuring quality, and constantly launches various new products independently researched and developed. The company adheres to the enterprise spirit of "scientific and technological innovation, truth-seeking and enterprising, high-quality and efficient, harmonious and healthy", constantly seeks innovation and breakthrough, and gradually makes the company become a modern, high-tech pharmaceutical enterprise. In the future, SAPS will adhere to the market-oriented, development oriented theme and technological innovation as the core. With the goal of protecting and promoting people's health and improving people's well-being. We are sure that the infinite "love" of sapeus will spread all over China and go to the world.

本文链接: https://www.waitui.com/brand/a5a71ec58.html 联系电话:请联系客服添加

千城特选小程序码

7×24h 快讯

中关村特色产业园营业总收入首次破万亿元

2024年中关村40家特色产业园营业总收入突破万亿元。记者从北京市科委、中关村管委会了解到,这是中关村特色产业园营收总规模首次破万亿元。 (新华社)

37分钟前

优步CEO:马斯克拒绝合作,将在无人驾驶出租车领域与特斯拉竞争

优步CEO达拉·科斯罗萨希在迈阿密举行的未来投资倡议研究所(FII)会议上表示,马斯克无意将特斯拉的RoboTaxi纳入优步平台,这意味着优步将在自动驾驶领域与特斯拉展开直接竞争。科斯罗萨希表示,他曾与马斯克就自动驾驶出租车业务进行过讨论。然而,马斯克似乎倾向于让特斯拉独立开发和运营这项服务,而非与优步等现有平台合作。他说:“所以在某种程度上,在奥斯汀,我们和Waymo将在特斯拉RoboTaxi推出时与特斯拉竞争。”(新浪财经)

38分钟前

北京地区民营企业进出口连续上涨15年

北京海关最新发布的统计数据显示,2024年,北京地区民营企业进出口总值4354亿元,同比增长11.9%,连续15年保持增长。其中,出口增长35.3%,进口增长3.4%,进出口规模和比重均创历史新高。值得注意的是,北京地区民营企业绿色低碳产业出口增长120.5%,其中标志性商品风力发电机组、锂离子蓄电池、光伏产品分别出口29.9亿元、11.5亿元、4.9亿元,分别增长98%、206%、128.5%。(新华社)

38分钟前

广汽丰田铂智 3X 将于 3 月 6 日上市,搭载 Momenta 5.0 智驾系统

2 月 22 日,据易车报道,广汽丰田旗下全新纯电动 SUV 铂智 3X 将于 3 月 6 日上市。该车已经于去年 12 月开启盲订,预售价区间 10 万-20 万元。该车配备 14.6 英寸悬浮式中控屏、8.8 英寸液晶仪表,采用 Momenta 5.0 高阶智驾,全系标配高通骁龙 8155 芯片,搭载英伟达 DRIVE AGX Orin X,算力达 254TOPS;配备 27 个传感器矩阵,包括 11 个高清摄像头、12 个超声波雷达、3 个毫米波雷达、1 个激光雷达。(it之家)

38分钟前

网传幼儿园将免费系误读,学前教育普及普惠不等于免费

近日,在多个社交平台上有自媒体发布消息称,从今年起一些地区的幼儿园将免费,网传信息多声称这是“教育部公布消息”,不少内容还附上了一份幼儿园免费地区的名单。还有自媒体发文表示,学前教育将纳入义务教育。一时间在家长群体中引发不小的反应。对此,多地教育部门都表示,尚未收到相关政策和通知。记者在多方求证后证实,这些内容要么是无凭无据的假消息,要么就是对“学前教育普及普惠”政策的误读。(新浪财经)

38分钟前

本页详细列出关于天目山药业的品牌信息,含品牌所属公司介绍,天目山药业所处行业的品牌地位及优势。
咨询